Skip to main content

biote Corp.

corporate_fare Company Profile

biote Corp.

BTMD·NASDAQ·Life Sciences·CIK 0001819253

Biote Corp. operates a high-growth practice-building business in the hormone optimization space. The company provides components to Biote-certified practitioners to help them establish, build, and implement programs for optimizing hormone levels using personalized solutions for patients. The Biote Method is a comprehensive, end-to-end practice building platform that offers Biote-certified practitioners education, training, and certification, practice management software, inventory management software, information on available hormone replacement therapy (HRT) products, and digital and point-of-care marketing support. Biote also sells a complementary line of Biote-branded dietary supplements. The company generates revenue by charging Biote-partnered clinics fees related to the Biote Method and from the sale of Biote-branded dietary supplements. Biote-certified practitioners offer bioidentical hormone therapy, which is a segment of the HRT market. As of 2020, the total U.S. market opportunity for HRT products exceeded $7 billion and is projected to grow 7% annually through 2026.

biote Corp. (NASDAQ:BTMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 15 items for BTMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 8/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for BTMD spans 10-Q, 4, 8-K, 8-K/A.

Recent high-impact activity:

  • Biote 10-Q: Covenant Breach Waived, Cash Falls to $8.9M, Material Weakness Persists
  • Q3 Revenue Falls 9.6% as Biote's Turnaround Stalls; Guidance Held
  • Executive Chairman Marc Beer Buys $202K of Biote Stock
  • Biote Q2 Loss Deepens, Material Weakness Lingers, and CEO Transition Concludes
  • Biote Swings to Q2 Loss, Slashes Full-Year Outlook as Recall Fallout Persists

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$192.22M
Net Income
$27.05M
Diluted EPS
$0.74
Op. Cash Flow
$35.19M
Free Cash Flow
$30.18M
Operating Income
$35.55M
Cash & Equivalents
$24.12M
Total Debt
$102.03M
Debt / Equity
-1.74×
Net Margin
14.1%
Shares Outstanding
31.28M sh
Source: 10-K · filed 2026-03-13 · accession 0001193125-26-106099

Short Interest & Short Volume

10.21 days to cover

FINRA reported short interest of 841,390 shares in BTMD as of the October 30, 2026 settlement, a 28.8% decrease from the prior period — about 10.2 days to cover at its recent average daily volume. On November 20, 2026, 36.3% of BTMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)841,390 shares as of October 30, 2026
Change vs prior period▼ 28.8%
Days to cover10.21 at avg daily volume of 82,442
Daily short volume (FINRA facilities)36.3% of 19,636 shares on November 20, 2026
5-day average short volume39.2%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with B →
$0.8105 -0.52% today
52-week range · as of 2026-11-09 $0.8105 – $2.9
Market cap
$45.35M
Volume
37.8K (0.4× avg)
3-mo avg 99.4K
Live data · 2026-11-22 03:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BTMD - Latest Insights

BTMD
Nov 09, 2026, 5:07 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.11
Real-time Price: $0.8105 info
Change: -$0.2995 (-27%) info
Market Cap: $45.352M info
BTMD
Nov 04, 2026, 4:11 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $0.8105 info
Change: -$0.4195 (-34%) info
Market Cap: $45.352M info
BTMD
Aug 12, 2026, 4:25 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $0.8105 info
Change: -$0.7395 (-48%) info
Market Cap: $45.352M info
BTMD
Aug 07, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.53
Real-time Price: $0.8105 info
Change: -$0.7149 (-47%) info
Market Cap: $45.352M info
BTMD
Aug 05, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $0.8105 info
Change: -$1.16 (-59%) info
Market Cap: $45.352M info
BTMD
Jun 17, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $2.27
Real-time Price: $0.8105 info
Change: -$1.46 (-64%) info
Market Cap: $45.352M info
BTMD
Jun 02, 2026, 5:17 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.15
Real-time Price: $0.8105 info
Change: -$1.34 (-62%) info
Market Cap: $45.352M info
BTMD
May 11, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.21
Real-time Price: $0.8105 info
Change: -$1.40 (-63%) info
Market Cap: $45.352M info
BTMD
May 06, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.14
Real-time Price: $0.8105 info
Change: -$1.33 (-62%) info
Market Cap: $45.352M info
BTMD
Apr 03, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.59
Real-time Price: $0.8105 info
Change: -$0.7795 (-49%) info
Market Cap: $45.352M info
BTMD
Apr 02, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.59
Real-time Price: $0.8105 info
Change: -$0.7795 (-49%) info
Market Cap: $45.352M info
BTMD
Mar 13, 2026, 4:04 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.40
Real-time Price: $0.8105 info
Change: -$0.5895 (-42%) info
Market Cap: $45.352M info
BTMD
Mar 11, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.74
Real-time Price: $0.8105 info
Change: -$0.9295 (-53%) info
Market Cap: $45.352M info
BTMD
Mar 11, 2026, 4:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.71
Real-time Price: $0.8105 info
Change: -$0.8995 (-53%) info
Market Cap: $45.352M info
BTMD
Jan 26, 2026, 5:21 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.16
Real-time Price: $0.8105 info
Change: -$1.35 (-62%) info
Market Cap: $45.352M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets